Found vs Embody: Biology-first programs vs low-cost GLP-1 plans
Found vs Embody is a comparison between a biology-first, medically supervised weight loss program and a low-cost, prescription-forward compounded GLP-1 service. Early verdict: choose Found if you want a personalized, insurance-friendly program built around metabolic biology; choose Embody if you want the lowest advertised cash entry price and fast free shipping.
Explore Found plans starting as low as $39
How they differ: personalization, pricing, and delivery
Found emphasizes a biology-first approach, with personalized medically supervised programs that target hormones, metabolism, sleep, and behavior. Found advertises affordable monthly plans and handling insurance paperwork, and states you can get started for as low as $39. Embody focuses on a lean, direct-pay model offering compounded semaglutide at $69/month and tirzepatide at $119/month, with no insurance and free 1-2 day shipping after approval.
Distinctive difference 1: Program style and personalization
Found: Personalized medically supervised weight loss program tailored to your biology. The provider states it builds programs around individual metabolic biology rather than a single medication protocol for all patients.
Embody: Prescription and telemed visits included, but the model is described as a no-frills GLP-1 program focused on providing compounded medication with fewer premium features such as integrated coaching or advanced monitoring.
Distinctive difference 2: Pricing model and insurance
Found: Advertises affordable monthly plans, get started for as low as $39, and states most insurance is accepted. Found also highlights handling insurance paperwork and mentions Medicare GLP-1 Bridge Program details for eligible Part D members.
Embody: Flat locked in monthly pricing at $69/month for compounded semaglutide or $119/month for compounded tirzepatide. Embody explicitly states No insurance and No prior authorization required. The $69 semaglutide pricing is presented as a limited-time offer and final pricing may vary based on dose and clinician recommendation.
See Embody semaglutide at $69/month
Distinctive difference 3: Medication options and regulatory notes
Found lists both compounded semaglutide and tirzepatide among options and notes that compounded GLP-1s are not FDA-approved, are not evaluated for safety or efficacy by FDA, and are not available in all states. Found also states some medications are FDA-approved for conditions other than weight and includes multiple regulatory qualifiers and offer details.
Embody offers compounded semaglutide and compounded tirzepatide and likewise notes compounded medications are not FDA-approved finished products. Embody advertises that medication ships in 1-2 days after approval and that compounded medications use the same active ingredients as branded GLP-1s, while emphasizing that no branded Ozempic, Wegovy, or Zepbound are provided.
Distinctive difference 4: Delivery speed and commitments
Found: Emphasizes insurance acceptance, flexible pricing, and membership plan options. Found mentions cancel anytime language for plans and varying membership starts depending on billing choices.
Embody: Highlights free shipping and 1-2 day delivery after clinician approval, no monthly membership, cancel anytime, and same price every dose. Embody positions itself as a fast, straightforward option with quick delivery and no long-term commitment.
Side-by-side snapshot
| Criteria | Found | Embody |
|---|---|---|
| Primary approach | Biology-first personalized program | Prescription-forward, no-frills GLP-1 delivery |
| Starting price | Get started for as low as $39 | $69/month for compounded semaglutide |
| Insurance | Most insurance now accepted; handles paperwork | No insurance. Direct pay only |
| Medication types | Compounded semaglutide, tirzepatide, branded options via insurance mention | Compounded semaglutide and tirzepatide only; no branded products |
| Shipping and delivery | Not specified in source for delivery speed | Free shipping, arrives in 1-2 days after approval |
| Commitment | Cancel anytime; membership options available | No monthly membership; cancel anytime |
What evidence does not supply
The sources do not supply comparative clinical effectiveness, detailed state eligibility lists, or exact copay amounts across insurers. They each include regulatory notes that compounded medications are not FDA-approved; do not infer safety or clinical outcomes beyond these statements.
Choose Found if…
you want a personalized, medically supervised program that centers on metabolic biology, prefer insurance support and paperwork handled by the provider, and want plan options beginning as low as $39.
Start Found’s biology-first program
Choose Embody if…
you prioritize the lowest advertised cash entry price and fast free shipping with no insurance required, for example compounded semaglutide at $69/month and tirzepatide at $119/month, with quick 1-2 day delivery after approval.
Get Embody compounded GLP-1s with fast shipping
Compare Found membership and insurance options
Primary keyword coverage: Found vs Embody. This comparison uses only the supplied source facts and preserves stated qualifiers, pricing, and regulatory notes.